Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.985 USD | +5.06% | -0.99% | +12.67% |
Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
Apr. 18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.55% | 734M | |
+25.84% | 661B | |
+26.74% | 566B | |
-6.67% | 352B | |
+20.38% | 332B | |
+2.72% | 283B | |
+13.51% | 231B | |
+4.70% | 200B | |
-9.37% | 195B | |
-5.22% | 145B |
- Stock Market
- Equities
- OCUL Stock
- News Ocular Therapeutix, Inc.
- Piper Sandler Adjusts Ocular Therapeutix Price Target to $15 From $10, Maintains Overweight Rating